Lewis lung carcinoma progression is facilitated by TIG-3 fibroblast cells

Anticancer Research

Volumn 33, Issue 9, 2013, Pages 3791-3798

  Yamauchi, Yoshikane ^a   Izumi, Yotaro ^a   Asakura, Keisuke ^a   Kawai, Kenji ^b   Wakui, Masatoshi ^a   Ohmura, Mitsuyo ^a   Suematsu, Makoto ^a   Nomori, Hiroaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Fibroblast; Invasion; LLC cells; Lung cancer; TGF beta; TIG 3

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; SIMVASTATIN; SMALL INTERFERING RNA; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL ASSAY; CELL CULTURE; CELL INVASION; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; FIBROBLAST CULTURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LUNG FIBROBLAST; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE TUMOR; TUMOR INVASION; WESTERN BLOTTING;

FIBROBLAST; INVASION; LLC CELLS; LUNG CANCER; TGF-BETA; TIG-3;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CELL LINE; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DISEASE PROGRESSION; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84885008130     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Beacham DA and Cukierman E: Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 15: 329-341, 2005.
2. Proia DA and Kuperwasser C: Stroma: Tumor agonist or antagonist. Cell Cycle 4: 1022-1025, 2005.
3. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011, 1999.
4. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005.
5. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926, 2008.
6. Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW and Banerjee D: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339, 2008.
7. Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, Onder TT, Wang ZC, Richardson AL, Weinberg RA and Orimo A: Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci USA 107: 20009-20014, 2010.
8. Stuelten CH, Busch JI, Tang B, Flanders KC, Oshima A, Sutton E, Karpova TS, Roberts AB, Wakefield LM and Niederhuber JE: Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-β mediated mechanism in a mouse xenograft model of breast cancer. PLoS One 5: e9832, 2010.
9. Wang J, Ying G, Jung Y, Lu J, Zhu J, Pienta KJ, and Taichman RS: Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression. Cancer Res 70: 471-480, 2010.
10. Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, Sime PJ and Phipps RP: More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 35: 297-325, 2006.
11. Egeblad M, Littlepage LE and Werb Z: The fibroblastic coconspirator in cancer progression. Cold Spring Harb Symp Quant Biol 70: 383-388, 2005.
12. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA and Weaver VM: Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254, 2005.
13. Matsuo M, Kaji K, Utakoji T and Hosoda K: Ploidy of human embryonic fibroblasts during in vitro aging. J Gerontol 37: 33-37, 1982.
14. Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Kitajima M, Takechi T, Okabe H and Fukushima M: Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice. Clin Cancer Res 5: 883-889, 1999.
15. Institute for Laboratory Animal Research: Guide for the care and use of laboratory animals, 8th ed. Washington (DC): National Academies Press., 2011.
16. Kimmelman AC, Hezel AF, Aguirre AJ, Zheng H, Paik JH, Ying H, Chu GC, Zhang JX, Sahin E, Yeo G, Ponugoti A, Nabioullin R, Deroo S, Yang S, Wang X, McGrath JP, Protopopova M, Ivanova E, Zhang J, Feng B, Tsao MS, Redston M, Protopopov A, Xiao Y, Futreal PA, Hahn WC, Klimstra DS, Chin L and DePinho RA: Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci USA 105: 19372-19377, 2008.
17. Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D and Jain RK: Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 107: 21677-21682, 2010.
18. Popik W and Inglot AD: Interactions of interferons and transforming growth factors during clonal growth of mouse or human cells in soft agar and in mice. Int J Cancer 40: 108-113, 1987.
19. Massague J and Like B: Cellular receptors for type β transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem 260: 2636-2645, 1985.
20. Seoane J: The TGFβ pathway as a therapeutic target in cancer. Clin Transl Oncol 10: 14-19, 2008.
21. Meyer-Ter-Vehn T, Katzenberger B, Han H, Grehn F and Schlunck G: Lovastatin inhibits TGF-β-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 49: 3955-3960, 2008.
22. Watts KL, Sampson EM, Schultz GS and Spiteri MA: Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts. Am J Respir Cell Mol Biol 32: 290-300, 2005.
23. Watts KL and Spiteri MA: Connective tissue growth factor expression and induction by transforming growth factor-β is abrogated by simvastatin via a Rho signaling mechanism. Am J Physiol Lung Cell Mol Physiol 287: L1323-1332, 2004.
24. Song CY, Kim BC and Lee HS: Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-β1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells. Transl Res 151: 27-35, 2008.
25. Vieira JM Jr., Mantovani E, Rodrigues LT, Delle H, Noronha IL, Fujihara CK and Zatz R: Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 20: 1582-1591, 2005.
26. Zhang W, Li Q, Wang L and Yang X: Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats. Pediatr Nephrol 23: 2185-2194, 2008.
27. Konstantinopoulos PA, Karamouzis MV and Papavassiliou AG: Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov 6: 541-555, 2007.
28. Kuoppala J, Lamminpaa A and Pukkala E: Statins and cancer: A systematic review and meta-analysis. Eur J Cancer 44: 2122-2132, 2008.
29. Sassano A and Platanias LC: Statins in tumor suppression. Cancer Lett 260: 11-19, 2008.